CA-SUGARCRM
14.1.2020 17:02:09 CET | Business Wire | Press release
SugarCRM Inc.® , the company that enables organizations to create customers for life, today announced its Winter ‘20 release, showcasing a new renewals console, along with additional features designed to improve the lead funnel, increase renewal rates for recurring revenue models, and optimize first-response resolution rates inside customer support centers.
The Renewals Console, a feature within Sugar Sell , is a significant differentiator for Sugar. Where other CRMs require extensive customization or third-party integration for duration-based renewable services, Sugar is providing this feature as core functionality.
“The Renewals Console can have an immediate impact on the bottom line, automating renewals management and incorporating subscription customers into ongoing marketing efforts,” said Craig Charlton, CEO of SugarCRM. “This is perfectly aligned with our no-touch information philosophy and Sugar’s commitment not only to understanding but also to where the CX industry is heading, but anticipating the needs of our customers as a result.”
Other highlights of the Winter ‘20 release include:
Sugar Market improves email bot click detection, allowing marketers to better understand prospect interactions by differentiating between bot and human traffic. Marketers get a more accurate picture of email campaign response rates, ensuring reliable marketing spend on activities that drive real engagement.
Sugar Serve provides valuable time-aware case tracking allowing customer service leaders to optimize team productivity by uncovering which types of cases require the most attention. Customer Service organizations can set up simple to complex business rules to measure and monitor first response SLAs and ensure customers’ SLA requirements are met.
Rounding out the release is the rollout of Sugar tagging on Sugar Mobile. Users can now create new tags, remove existing ones, and search by tag from their mobile device.
“We’re excited about this release for many reasons,” said Rich Green, Sugar Chief Product Officer and CTO. “Subscription models are becoming increasingly common in businesses worldwide, making native support for recurring revenue management critical. And underlying this and other new features are our time-aware CX technologies. We continue to make a differentiated impact on the CX landscape with our solutions, all with the goal of helping our customers create customers for life.”
About SugarCRM
SugarCRM is a customer experience solutions leader enabling businesses to deliver highly relevant, personalized attention throughout the lifetime of a relationship. Our innovative time-aware CX platform provides historical insight into customers, enabling companies to understand, strengthen and communicate more effectively. The result? Accelerated demand generation, increased revenue, superior customer care and elevated loyalty.
The Sugar Cloud portfolio aligns sales, marketing and customer service professionals to make business more predictable, supercharging growth. Sugar fuels midmarket and enterprise business by enabling high-impact, value-added activities that create customers for life.
Based in Silicon Valley, SugarCRM is backed by Accel-KKR. Nearly 4500 businesses in over 120 countries rely on SugarCRM.
To learn more visit https://www.sugarcrm.com or follow @SugarCRM.
NOTE: SugarCRM and the SugarCRM logo are registered trademarks of SugarCRM Inc. Third-party trademarks mentioned are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005068/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom